We have updated the ordering process to allow all products and services to be purchased with a single PO, please address all POs to Horizon Discovery Biosciences Limited. Contact us for assistance.

CHOSOURCE™ CHO-K1                GS knockout expression platform

Empowering biotherapeutic production

Drive efficiencies during development and production

  • Freedom to choose - any media, vector or CRO/CMO
  • Freedom to operate – no patent or IP risks
  • Maintain profitability throughout product life cycle - royalty-free licensing

Gene editing CHO cell services

  • Improve your CHO cell performance
  • Meet demands for cost-effective biomanufacturing
  • Ensure a clear IP position with freedom to operate

News highlights

  • CHOSOURCE™ platform supports development of immunotherapy for autoimmune diseases
  • CHOSOURCE™ platform offered for COVID-19-related therapeutics and diagnostics
  • Multi-product use license of GS knockout CHO K1 cell line granted to NGM Bio
  • Glenmark adopts CHO cell line into biomanufacturing process

Regulatory Compliant – no royalty fees

Innovative and flexible approach to licensing

How does the CHOSOURCE platform help our customers?

See how Elanco, Jounce Therapeutics, and Just-Evotech Biologics have optimized their biotherapeutic workflows with our CHOSOURCE cells.